Dallas, TX — Dallas, Texas

Dallas, TX is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Dallas, TX has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD), Neovascular (Wet) Age-Related Macular Degeneration.

Sponsors: EyeBiotech Ltd., Ollin Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dallas, TX?

Dallas, TX has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dallas, TX conducted?

Dallas, TX has 5 clinical trials on record, with 3 currently active. Their work covers Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD), Neovascular (Wet) Age-Related Macular Degeneration.

Is Dallas, TX accredited by Crixeo Health?

Dallas, TX has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dallas, TX?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.